| Aravind Pothineni, MD | |
|
1723 Broadway Suite 205, Cape Giradeau, MO 63701 | |
| (573) 331-7830 | |
| Not Available |
| Full Name | Aravind Pothineni |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 1723 Broadway Suite 205, Cape Giradeau, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124215124 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 2014012500 (Missouri) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | NA (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeasthealth | Cape girardeau, MO | Hospital |
| Southeasthealth Center Of Stoddard County | Dexter, MO | Hospital |
| Poplar Bluff Regional Medical Center | Poplar bluff, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Missouri Hospital Physicians Llc | 9133024334 | 186 |
News Archive
During the release of its five-year plan to help drive down high maternal death and fertility rates in low-income countries, the World Bank on Tuesday said "that family planning and other reproductive health services have fallen off the radar of many governments, donors and aid agencies," Reuters reports.
Ben-Gurion University of the Negev (BGU) researchers have determined that preeclampsia is a significant risk factor for long-term health issues, such as chronic hypertension and hospitalizations later in life.
One in five U.S. adults will experience a mental illness in their lifetime, according to the National Alliance of Mental Health. But standard treatments can be slow to work and cause side effects.
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.
› Verified 3 days ago
| Entity Name | Southeast Missouri Hospital Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558311522 PECOS PAC ID: 9133024334 Enrollment ID: O20031201000775 |
News Archive
During the release of its five-year plan to help drive down high maternal death and fertility rates in low-income countries, the World Bank on Tuesday said "that family planning and other reproductive health services have fallen off the radar of many governments, donors and aid agencies," Reuters reports.
Ben-Gurion University of the Negev (BGU) researchers have determined that preeclampsia is a significant risk factor for long-term health issues, such as chronic hypertension and hospitalizations later in life.
One in five U.S. adults will experience a mental illness in their lifetime, according to the National Alliance of Mental Health. But standard treatments can be slow to work and cause side effects.
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aravind Pothineni, MD 1723 Broadway St Ste 205, Cape Girardeau, MO 63701-4556 Ph: (573) 331-7830 | Aravind Pothineni, MD 1723 Broadway Suite 205, Cape Giradeau, MO 63701 Ph: (573) 331-7830 |
News Archive
During the release of its five-year plan to help drive down high maternal death and fertility rates in low-income countries, the World Bank on Tuesday said "that family planning and other reproductive health services have fallen off the radar of many governments, donors and aid agencies," Reuters reports.
Ben-Gurion University of the Negev (BGU) researchers have determined that preeclampsia is a significant risk factor for long-term health issues, such as chronic hypertension and hospitalizations later in life.
One in five U.S. adults will experience a mental illness in their lifetime, according to the National Alliance of Mental Health. But standard treatments can be slow to work and cause side effects.
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.
› Verified 3 days ago